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Abstract 
Background: The rates of angioedema amongst African American patients using angiotensin- 
converting- enzyme- inhibitors (ACE-I) are five times greater than non-African American 
counterparts (01.-07 percent vs. 0.5-3.5 percent). Although ACE-I agents are widely prescribed, 
they have less therapeutic control in hypertension amongst this group of patients and high 
incidences of life threating side effects.  
Methods: The purpose of this quality improvement (QI) project was to assess provider 
knowledge related to established guidelines from the Joint National Committee  (JNC) on 
hypertension management, as well as their knowledge of the side effects of ACE-I for African 
American patients.  A pre interventions survey was conducted to assess knowledge of established 
guidelines for hypertension management and risks associated with use of ACE-I in African 
American patients. The staff was then educated on current guidelines as well as where to access 
them, and also on the risks of ACE-I and alternative options for African American patients and a 
post intervention survey was issued  to assess knowledge gained from the intervention.  
Results: Following the educational intervention, all participants were able to identify resources 
related to guidelines for hypertensive management. However, only 75% of staff were able to 
recall potential adverse side effects of ACE-I use in African American patients.  
Conclusion:  The results of this QI project support the effectiveness of an  educational program 
addressing  ethnic considerations in the prescribing of ACE-I for African American patients. 
Keywords: African American, angioedema, hypertension, ACE-I 
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Hypertensive Management for African American Patients 
Introduction   
 Hypertension among African Americans is proportionately higher than other 
races.  By the age of sixty-five, African American patients are 65% more likely to have 
developed hypertension (Ferdinand, 2003) (see Appendix A for hypertension 
demographic bar graph). Many genetic, cultural, pathological and even geographical 
components make this population susceptible to hypertension (Ferdinand, 2003; 
Ogedegbe, 2015).  
Background 
 Although well recognized institutions such as the American Society of 
Hypertension have developed effective hypertension management; leading institutions 
such as the American College of Cardiology (ACC) and the American Heart Association 
(AHA) have limited research regarding ethnic considerations for hypertension. The need 
for ethnic based hypertension management is needed and proper pharmaceutical drug 
selection must be tailored to patient needs. For example, the use of angiotensin 
converting enzyme inhibitors (ACE-I) amongst African American patients has shown 
decreased effectiveness and increased morbidity and mortality (Ferdinand, 2003).  
Despite the evidence, many providers still prescribe ACE-I as first line management with 
this population. The gap in evidence vs. practice can be attributed to the lack of 
representation in hypertensive studies amongst African Americans (Ogedegbe, 2015).  
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Problem Statement  
 Due to genetic makeup and ethnic components, African Americans respond 
differently to the treatment of hypertension with ACE-I (Ogedegbe, 2015). Appropriate 
education on current guidelines and recommendations is necessary to ensure proper 
prescription thus decreasing adverse reactions. The increased risk of angioedema in 
African Americans prescribed ACE-I for hypertension requires a need for culturally 
appropriate guidelines and education for prescribing providers. Providing the current 
published guidelines on hypertensive management and evaluating the competency of 
local providers, will help reiterate the importance of ethnic consideration in hypertensive 
management. Furthermore, decreases in adverse reaction and better therapeutic control 
will be evident. 
Organizational “gap” Analysis of Project Site 
 The proposed site is a primary care facility. The site has no clear guidelines for 
the management of hypertension and their reference resources are outdated. Although this 
capstone project does focus on African American patients, the established guidelines 
consist of best practice for all patients including those with chronic illnesses (James et al., 
2014). The providers will be given these resource to improve their practice and 
prescribing methods. The purpose of the capstone project is to ensure that 100% of staff 
know how to access the current guidelines on hypertension management to adequately 
prescribe medication for African American patients. This will consequently decrease the 
high prescriptions of ACE-I amongst this population as first line management which has 
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proven to be less effective in controlling hypertension along with carrying life threatening 
side effects (angioedema). 
Review of the Literature 
A comprehensive review was conducted using CINAHL complete, PubMed and 
UpToDate.  The following Medical Subject Headings (MeSH) terms were used for 
CINAHL: African American and/or blacks, hypertension, ACE and angioedema.  
UpToDate search consisted of MeSH terms of angioedema and ACE inhibitor.  The 
MeSH terms used on PubMed included use of angioedema and African Americans. 
The CINAHL search resulted in 55,575 articles.  This was reduced by selecting 
academic journals and eliminating the MeSH term “black” resulting in four articles.  
UpToDate resulted in 52 articles and was further reduced by using specific inclusion 
criteria terms such as “African Americans” which resulted in four articles.  PubMed 
originally produced 24 articles and was further narrowed by reducing the publication date 
to the last 10 years resulting in nine articles.  Boolean phrases of angioedema AND ACE 
AND African Americans OR Blacks resulted in a total of 17 possible articles. Due to the 
limited research amongst African Americans and hypertension, reducing the article to the 
standard last five years produced limited valid research to form a proper review of the 
data. A total of eight articles were selected to review the literature. The articles chosen 
consist of peer review, medical journals, nursing journals and practice guidelines.  
 
ACE-I Prescription in African Americans 
ALTERNATIVES TO ACE-I IN AFRICAN AMERICANS 8 
 Ogedegbe (2015) proposes that the large disparity between hypertension 
management and African Americans, is the lack of research focused around their unique 
medical needs.  The continued prescription of ACE-I for management of African 
Americans not only has adverse consequences, such as angioedema, but the therapeutic 
effects have proven to be futile (Ogedegbe, 2015). Kupfer, Ramachadran and Tessler 
(2010) conducted extensive research and case studies of African Americans who 
developed angioedema after ACE-I use. The studies demonstrated severe angioedema 
which resulted in tracheostomies and acute, long term level care (Kupfer et al., 2010). 
The research further identified extreme risk factors in ACE-inhibitor induced angioedema 
due to the swelling not being preceded by general warning signs (uticaria, rash) and the 
presence of normal C4 and C1 inhibitor levels (Kupfer et al., 2010). Kupfer et al. (2010) 
discussed that genetic factors such as vasoactive peptide bradykinin may play a role in 
the susceptibility to ACE-I induced angioedema in African Americans. The bradykinin 
enzyme can cause vasodilation and capillary leakage which can cause angioedema 
(Kupfer et al., 2010). Furthermore, evidence-based treatment for reactions such as use of 
“corticosteroids, antihistamines and catecholamine’s have no proven efficacy in the 
treatment of ACE inhibitor-induced angioedema” (Kupfer et al., 2010).  Ferdinand (2003) 
conducted further research which concluded that other first line options, such as thiazide- 
type diuretics and calcium channel blockers not only decreased the occurrence of 
angioedema, but provided better blood pressure control in African Americans. Ferdinand 
(2003) also reviewed one of the very few studies that included African Americans. This 
study was called the Antihypertensive and Lipid Lowering Treatment to Prevent Heart 
Attack Trial (ALLHAT). This trial further confirmed the need for changes in first line 
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treatment for African Americans by demonstrating increased stroke risk with ACE-I use 
compared to non-African American groups (Ferdinand, 2003).   
Angioedema and ACE-Inhibiter Frequency  
Morimoto et al. (2003) explored ways to eliminate the use of ACE-I because of 
the increase of adverse drug side effects. Not only was an increased risk for angioedema 
apparent with African Americans but also East Asians developed cough and 
hyperkalemia (Morimoto et al., 2003). This study went a step beyond angioedema and 
explored the other comorbidities associated with ACE-I use which further proved ethnic 
based selection for antihypertensive would be beneficial. Guyer and Banerji (2015) as 
well as Lin and Shah (2008) found that ACE-I use was the leading cause of drug induced 
angioedema in the United States (see Appendix B for angioedema plot chart).  
The rate of emergency room visits due to angioedema from ACE-I, is reported to 
be as high as 40% (Guyer & Banerji, 2015).  With over 40 million patients in the United 
States prescribed ACE-I for hypertension, myocardial infarction, heart failure, diabetes 
and chronic kidney disease; the risk for adverse effects is exponentially elevated (Guyer 
& Banerji, 2015). Two reported studies examined the rates of angioedema in patients 
taking ACE-Is: OCTAVE trial and ONTARGET trail (Guyer & Banerji, 2015). The later 
demonstrated a  rate of 68% in developing angioedema within six months with the use of 
enalapril, an ACE-I (Guyer & Banerji, 2015). These results were five times greater in 
African American patients (Flattery, 2011). A multicenter study of the ER revealed that 
the most common presenting symptoms were shortness of breath, dyspnea, tongue and lip 
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swelling (Flattery, 2011).  Twenty percent of these patients developed life threatening 
airway obstruction (Flattery, 2011).  
Evidence-Based Practice: Verification of Chosen Option 
 The current developed guidelines through the JNC-8 outline a stepwise approach 
in managing hypertensive patients, decreasing adverse drug effects and promoting 
therapeutic control (James et al., 2014). These guidelines are supported by clinical 
evidence that have been developed for use by providers in all settings. However, current 
research and literature has shown a disconnect in the published practices and clinical 
guidelines which demonstrates a need for practice evaluation and interventions.  
Theoretical Framework 
 Campinha-Bacote (2002) developed a theoretical framework surrounding the idea 
of cultural competence in healthcare. Her model focuses on the patients as the teachers 
and providers as continually tailoring and changing their care to fit the patient (students) 
(Campinha-Bacote, 2002). Her framework of cultural competence, requires that the 
provider continually learn and strive to become cultural competent. This entails tailoring 
medications and teachings to fit our patients specific need. In the case of ACE-I use and 
African American patients; the framework would urge providers to recognize the 
negative benefits in this population and use this knowledge to change prescription 
protocols to meet the patients’ needs.  
Campinha-Bacote’s (2002) theory encompasses a continuum of care model. It is 
projected  that cultural competency is attained along a continuum and that we are forever 
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learning new ways to treat our patients and achieve cultural competence. This model 
assumes that cultural competence is achieved through five distinct steps: cultural 
awareness, cultural knowledge, cultural skills, cultural encounters and last, cultural 
desire. If we do not have a desire to be culturally inclined, we will not take considerations 
of culture into our practice. 
Understanding that culture, ethnicity, and medication continue to change and 
improve; can better allow the provider to maintain an open mind and understand that all 
treatment option is not the same. Furthermore, Campinha-Bacote ascertains that there is a 
direct correlation in provider competence level and their ability to provide ethnic care. 
Providers who are more competent, through education, training and literature; for 
example, tend to have greater understanding and acceptability of cultural considerations 
in patient management. This is a key component in ensuring specific, attainable goals in 
managing patients of all ethnicities.  
Methods 
Project Design  
 This QI project provided education to healthcare providers and essential staff to 
ensure evidence- based prescribing practices in the management of hypertension in 
African Americans. A pre-assessment questionnaire was administered to assess the staff’s 
current knowledge on prescribing of anti-hypertensive medication (see Appendix H for 
the pre assessment questionnaire). Following the pre-assessment, the DNP student 
reviewed established hypertension guidelines and reviewed pre-designed pamphlets with 
providers and staff (see Appendix D for current JNC 8 guidelines). Following a period of 
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two weeks, a post intervention assessment was administered which included both the 
questions in the original questionnaire as well as open-ended questions where providers 
were able to note any potential barriers to implementation of the new evidence- based 
standards (See Appendix I for post intervention survey).  
Implementation Plan/Procedures 
Education was provided in the form of verbal presentation by the DNP student 
during individual meetings. Initially, the education was to be conducted as a group setting 
during staff meetings. However, due to the complexity and staffing of the office a group 
training was not possible. The presentation reviewed existing guidelines by the Joint 
National Committee (JNC) and handouts that included information related to ethnic 
considerations in hypertension management  (see Appendix E for DNP developed flyer). 
During time with staff, the DNP student assisted in clarifying educational material in 
regards to hypertension management with African American patients. The 
implementation lasted two weeks after receiving the educational materials. During this 
time the DNP student acted as a resource in obtaining additional information on 
established guidelines for clinical practice. 
Goals /Objectives 
The goals and objectives of this project was to ensure that 100% of prescribing 
staff and essential administration receive the published guidelines and understand the risk 
factors in prescribing ACE-I for African American patients. A post intervention survey 
was conducted after two weeks to review any barriers to implementation. Opportunities 
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for learning and dialogue was available by the DNP student to assist in clarification of 
current guidelines throughout implementation.  
Data Analysis 
Descriptive statistics were used to compare the results of the pre and post 
implementation survey. 
Description of the Medical Group and Patient Population  
The project took place in a primary care setting in the southwest. The 
demographics of the staff consisted of one medical doctor (MD), two Nurse practitioners 
(NP), one licensed vocational nurse (LVN) and 4 medical assistants (MA’s). The 
electronic charting system provides patient resources through Lippincott, Epocrates and 
Medscape.  The policies and procedure guidelines are developed by the managing 
physician who references Lippincott.  
The facility has an average patient census of 30 patients per day, 50% of which 
are state funded or government funded insurance and the additional 50% consisting of 
cash payment and PPO groups. The average population serviced at the clinical site 
consists of middle income households. The average patient age is 54 years old. The 
patient demographics are approximately 50% Hispanic, 30% African American, and 20% 
mixed race and other.  
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Ethics and Human Subjects Protection 
 Prior to the project being initiated, it was reviewed by the University of 
Massachusetts Amherst Institutional Review Board (IRB) and was determined to not 
meet criteria for requiring IRB approval. The project was classified as a QI project.  
Results 
The pre intervention survey demonstrated that 100% (n=8) of staff acknowledged 
that ethnic based consideration should be considered when prescribing medications. 
Seventy- five percent ( n=5) of the staff were aware that published guidelines for African 
American patient and hypertension existed however none were able to state which 
organization published these guidelines. Twenty-five percent (n=2) were able to cite a 
resource available to access prescribing information. Seventy-five percent(n=5) of staff 
agreed that it is very important for providers to consider a holistic approach when 
prescribing medications.  
 After educating the providers with the published information, three of the eight 
staff had additional questions regarding the project information. Further resources were 
provided on hypertension management from the American Heart Association (See the 
appendix I for AHA).  Following the educational intervention, all participants (n=8) were 
able to identify resources related to guidelines for hypertensive management. However, 
only 75% ( n=5) of staff was able to recall potential adverse side effects of ACE-I use in 
African American patients. Overall, the quality improvement project demonstrated a 25% 
(n=2) increase from the pre intervention survey (See Appendix J for charts). 
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Discussion/Interpretation 
The intervention improved staff knowledge of published hypertensive guidelines 
issued through the JNC. The initial pre intervention survey demonstrated a lack of 
knowledge related to where the published guidelines could be accessed, although all staff 
agreed that ethnic based guidelines should exist. Furthermore, providers were able to 
identify that potentially harmful side effects from pharmaceuticals can effect certain 
ethnic groups. 
Although published guidelines do exist, they may not be disseminated well 
throughout medical clinics due to a lack of accessibility or provider knowledge on how to 
access this resource. Many patients may not be receiving best practices related to 
prescribing of antihypertensive medications, which can ultimately effect their safety. 
Further clinical studies on African American patients need to be conducted to help 
understand ethnicity and pharmacopeia. 
Campinha-Bacote’s theoretical framework stresses the importance of utilizing the 
patient response to make culturally competent decisions in healthcare. The theory stresses 
the importance of treating the patient, not the disease, and learning to tailor our medical 
practices towards patient response. In regards to hypertensive management, we should be 
aware that there are increased risks in African American patients with use of ACE-I. 
Although this medication is affordable, highly prescribed, and generally well tolerated in 
others; it is imperative that we take time to assess our patient fully and review evidence-
based research and guidelines which support alternative options. 
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 When we incorporate ethnicity into the complexities of genetics and 
pharmacopeia, we need to consider patient response and patient trends. African 
Americans have specific needs due to their genetic makeup. Many medications will not 
work the same as their counterparts. Therefore, taking an individualized approach to 
prescribing all medications, not just antihypertensive, should encourage ethnic 
considerations. 
Facilitators and barriers. Educating the staff as a group, as originally planned 
proved to be difficult due to the staffing patterns at the office and the need for staff to 
attend patient care responsibilities. 
Conclusion 
The results of this QI project support the effectiveness of an  educational program 
in addressing  ethnic considerations in the prescribing of ACE-I for African American 
patients. This QI project demonstrated that there is a need for education and resources 
regarding the use of ACE-I in this population. Evidence-based practices related to the 
prescription of ACE-I need to be more widely disseminated. In addition, the use of 
Angiotensin II receptor blockers (ARB) should be further studied in African American 
patients as some studies suggest these should also be avoided. Further research in regards 
to ethnicity and response to hypertension  treatment should be conducted.  
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Appendix B 
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Appendix C 
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Appendix D 
 
 
 
Ethnic considerations in 
the management of 
hypertension amongst 
African Americans can 
aid in decreased 
mortality and morbidity. 
The Use of ACE-I, 
although popular, have 
detrimental side effects 
in African Americans and 
show poor management 
of cardiovascular control 
(Ogedegbe,, 2015). 
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Appendix E 
Table 1 
Budget analysis                                                                                                                          
Items                             Price                                                    Total 
Copies/ Materials $0.50 X 30=$15.00 
$5.50 poster board 
 
 
Time $55 X 10= $550  
Transportation/fuel $2.80 X 18 gallons= 
$50.40 
 
$620.90 
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Appendix F 
Table 2 
Timeline  
Week Objective Follow up 
1-2 Assessment of current staff 
knowledge 
Administer pre assessment 
Gather materials and 
organize time with medical 
director to approve and 
introduce material 
2-4 Provide established JNC 
guidelines and DNP 
developed handout 
Answer and clarify any 
questions from providers 
Provide additional 
established guidelines as 
needed 
1 month Administer post assessment Address any concerns and/ 
or barriers 
Provide resources and 
guidelines 
2 months Quantify data and analyze 
results 
Provide any additional 
resources to ensure 
longevity of guidelines 
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Appendix G 
Pre-intervention survey for hypertensive management in African Americans 
 
1) Were you aware that guidelines exist to help prescribe anti hypertensive for 
patients? 
 
Yes or No 
 
2) Do the published guidelines and handouts provide the tools needed to prescribe 
medication for this population? 
 
Strongly agree/ agree/ undecided/ disagree/ strongly disagree 
 
3) How likely will this capstone project help you to consider ethnicity in prescribing 
and diagnosing for future patient populations? 
 
Very frequently/ frequently/occasionally/ rarely/never 
 
4) How important is it for providers to consider a holistic approach (considering 
patients social, economical, cultural, ethnicity and religious backgrounds) in 
prescribing care and medications? 
 
Very important/ important/ moderately important/ of little importance/ 
unimportant 
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Appendix H 
Post intervention survey for hypertensive management in African Americans 
1) Were you aware that guidelines exist to help prescribe anti hypertensive for 
patients? 
 
Yes or No 
2) Do the published guidelines and handouts provide the tools needed to prescribe 
medication for this population? 
 
Strongly agree/ agree/ undecided/ disagree/ strongly disagree 
3) How likely will this capstone project help you to consider ethnicity in prescribing 
and diagnosing for future patient populations? 
 
Very frequently/ frequently/occasionally/ rarely/never 
 
4) How important is it for providers to consider a holistic approach (considering 
patients social, economical, cultural, ethnicity and religious backgrounds) in 
prescribing care and medications? 
 
Very important/ important/ moderately important/ of little importance/ 
unimportant 
 
5) What is one risk involved with ACE-I? 
 
6) Describe one reason why African American patients should avoid first line 
treatment with ACE-I? 
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Appendix I 
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Appendix J 
 
 
Figure 1. Staff demographics of capstone project 
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Figure 2. Pre intervention and post intervention survey comparison 
